Roche-partnered cell therapy company lays off most of its staff, loses CEO, CFO


A Watertown cell therapy company is laying off 60% of its staff and losing two executives as it presses pause on most of its programs.

Previous Dallas-based Healthmine appoints David DeWinter as new chief product officer
Next Texas A&M University, University Health's new partnership to focus on underserved communities